Cell Research Molecular Biology

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant

Xia, Shuai, Chan, Jasper Fuk-Woo, Wang, Lijue, Jiao, Fanke, Chik, Kenn Ka-Heng, Chu, Hin, Lan, Qiaoshuai, Xu, Wei, Wang, Qian, Wang, Chao, Yuen, Kwok-Yung, Lu, Lu, Jiang, Shibo
Springer Nature · 2022-04-01 · DOI 10.1038/s41422-022-00617-x

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →